Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants
Mitsushige Sugimoto, Masaki Murata, Takashi Kawai
Abstract
, anti-factor Xa activity) of DOACs are related to risk of major bleeding, plasma DOAC level and anti-FXa activity may be useful parameters for monitoring the anti-coagulate effect and identifying DOAC patients at higher risk of post-ESD bleeding.
Topics & Concepts
MedicineRivaroxabanEndoscopic submucosal dissectionGastrointestinal bleedingWarfarinAdverse effectAntithromboticCancerGastroenterologyInternal medicineSurgeryAtrial fibrillationGastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studiesGastrointestinal Tumor Research and Treatment